Welcome to our dedicated page for Firsthand Technology Value Fund news (Ticker: SVVC), a resource for investors and traders seeking the latest updates and insights on Firsthand Technology Value Fund stock.
Firsthand Technology Value Fund reports financial results as a publicly traded venture capital fund investing in technology and cleantech companies. Recurring updates center on NAV per share, net assets, portfolio values for public and private securities, cash and cash equivalents, and realized or unrealized investment results.
The fund's quarterly and annual releases also discuss private-company fair-value adjustments by its Valuation Committee under ASC 820, use of independent valuation input, portfolio-company performance, recent securities transactions, sector market multiples, and efforts to identify exit opportunities.
Firsthand Technology Value Fund (NASDAQ: SVVC) reported its top five holdings as of January 31, 2021, which encompass approximately 89.4% of its estimated total investments of $108 million, translating to $15.68 per share. The leading investment is in IntraOp Medical Corp. at 24.4%, followed by Wrightspeed, Pivotal Systems, Revasum, and SVXR. The fund holds various securities including preferred stocks and debt across these companies. More details will be disclosed in the upcoming quarterly report due in May 2021.
Firsthand Technology Value Fund (NASDAQ: SVVC) announced its preliminary net asset value (NAV) of $14.82 per share as of December 31, 2020. The Fund's top five holdings include IntraOp Medical, Wrightspeed, Pivotal Systems, Revasum, and SVXR, which together account for 88.7% of the Fund's total investments. Notably, IntraOp Medical represents 25.8% of the Fund's assets, the largest share. Total investments reached $99.7 million, or approximately $14.46 per share. The annual report will be filed by March 2021.
Firsthand Technology Value Fund (NASDAQ: SVVC) reported its top five holdings as of November 30, 2020, which include Pivotal Systems, IntraOp Medical, Wrightspeed, Revasum, and SVXR. Collectively, these holdings represent 89.7% of the fund's estimated total investments of approximately $102 million, translating to about $14.78 per share. Notably, Pivotal Systems accounts for 29.1% of this total, followed by IntraOp Medical at 21.7%. Full financial details will be disclosed in its annual report in March 2021.
The Firsthand Technology Value Fund (NASDAQ: SVVC) disclosed its top five holdings as of October 31, 2020, representing 87.2% of its estimated total investments of approximately $88 million or $12.75 per share. Key investments include Pivotal Systems (25.6%), IntraOp Medical (25.2%), and Wrightspeed (22.7%). Cash and cash equivalents stand at about $0.15 per share. Detailed financial statements will be available in the annual report in March 2021. The Fund primarily invests in technology and cleantech sectors and aims for long-term capital growth.
Firsthand Technology Value Fund (NASDAQ: SVVC) reported third-quarter financial results for the period ending September 30, 2020. The Fund's net assets decreased to approximately $95.2 million, or $13.81 per share, compared to $101.3 million or $14.70 per share at the end of Q2 2020. Portfolio values included approximately $93.2 million in public and private securities. The Fund reported $1.1 million in investment income and net investment income of approximately $262,000, but faced net realized and unrealized losses of around $6.4 million.
Firsthand Technology Value Fund (NASDAQ: SVVC) announced a preliminary net asset value (NAV) of $13.81 as of September 30, 2020. The Fund's top five holdings are Pivotal Systems, IntraOp Medical, Wrightspeed, Revasum, and SVXR, which collectively constitute 87.3% of the Fund's net assets. Total investments reached $95.5 million, approximately $13.85 per share. The complete financial statements and investment details will be disclosed in the upcoming 10-Q report in November 2020.
Firsthand Technology Value Fund (NASDAQ: SVVC) disclosed its top five holdings as of August 31, 2020, which include Pivotal Systems, IntraOp Medical, Wrightspeed, Revasum, and SVXR. These holdings constituted 88.3% of the Fund’s estimated total investments, valued at approximately $94 million, or $13.70 per share. Pivotal Systems accounted for 36.8% of the total investments, while IntraOp Medical and Wrightspeed made up 24.2% and 15.1%, respectively. The Fund plans to release its quarterly report on Form 10-Q in November 2020.
Firsthand Technology Value Fund (NASDAQ: SVVC) disclosed its top five holdings as of July 31, 2020, which include Pivotal Systems, IntraOp Medical, Wrightspeed, Revasum, and SVXR. The total investments of the Fund are approximately $99 million or $14.40 per share, with cash equivalents around $0.45 per share. The top five holdings account for 87.2% of total investments, highlighting concentrated exposure to these companies. A detailed financial report is expected in November 2020.
Firsthand Technology Value Fund, Inc. (NASDAQ: SVVC) reported its financial results for Q2 2020, with net assets increasing to approximately $101.3 million or $14.70 per share, up from $79.8 million or $11.58 per share at the end of Q1. The Fund’s portfolio, valued at approximately $101.4 million, included significant investment income of approximately $922 thousand and a net realized/unrealized gain of $21.3 million for the quarter. The Fund emphasizes ongoing portfolio management to enhance performance and identify exit opportunities.
As of June 30, 2020, Firsthand Technology Value Fund (NASDAQ: SVVC) reported a preliminary net asset value (NAV) of $14.70 per share and total investments of $102.0 million. The top five holdings amounted to 90.7% of the Fund's NAV, with Pivotal Systems representing 39.6%, followed by IntraOp Medical at 21.3%. The Fund plans to disclose complete financial statements in its upcoming Form 10-Q filing in August 2020. This Fund focuses on investing in technology and cleantech companies.